ACP Journal Club. Review: Contemporary oral contraceptives are associated with venous thromboembolism and stroke

Comment

Thomas DeLoughery. Ann Intern Med. 2013.

. 2013 Dec 17;159(12):JC11.

doi: 10.7326/0003-4819-159-12-201312170-02011.

No abstract available

Comment on

Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.
Peragallo Urrutia R, Coeytaux RR, McBroom AJ, Gierisch JM, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, Hasselblad V, Sanders GD, Myers ER. Peragallo Urrutia R, et al. Obstet Gynecol. 2013 Aug;122(2 Pt 1):380-389. doi: 10.1097/AOG.0b013e3182994c43. Obstet Gynecol. 2013. PMID: 23969809

Drospirenone-containing oral contraceptives may increase the risk of venous thromboembolism.
Jick SS. Jick SS. Evid Based Nurs. 2014 Jul;17(3):71. doi: 10.1136/eb-2013-101502. Epub 2013 Oct 29. Evid Based Nurs. 2014. PMID: 24170817 No abstract available.
Commentary on "Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review".
Cameron S. Cameron S. BJOG. 2013 Jun;120(7):811. BJOG. 2013. PMID: 23802311 No abstract available.
Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.
Zakharova MY, Meyer RM, Brandy KR, Datta YH, Joseph MS, Schreiner PJ, Rao GH, Divani AA. Zakharova MY, et al. Clin Appl Thromb Hemost. 2011 Aug;17(4):323-31. doi: 10.1177/1076029610368670. Epub 2010 Jun 7. Clin Appl Thromb Hemost. 2011. PMID: 20530058 Review.
Oral contraceptives and venous thromboembolism.
Dunn N. Dunn N. BMJ. 2009 Aug 13;339:b3164. doi: 10.1136/bmj.b3164. BMJ. 2009. PMID: 19679617 No abstract available.
Hormonal contraceptives and venous thromboembolism: an epidemiological update.
Plu-Bureau G, Maitrot-Mantelet L, Hugon-Rodin J, Canonico M. Plu-Bureau G, et al. Best Pract Res Clin Endocrinol Metab. 2013 Feb;27(1):25-34. doi: 10.1016/j.beem.2012.11.002. Epub 2012 Dec 21. Best Pract Res Clin Endocrinol Metab. 2013. PMID: 23384743 Review.